-
Je něco špatně v tomto záznamu ?
The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells
J. Stanislav, J. Mls, M. Červinka, E. Rudolf,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antitumorózní látky fytogenní farmakologie terapeutické užití MeSH
- apoptóza účinky léků fyziologie MeSH
- autofagie účinky léků fyziologie MeSH
- buňky HT-29 MeSH
- HCT116 buňky MeSH
- kamptothecin analogy a deriváty farmakologie terapeutické užití MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 nedostatek genetika MeSH
- nádory tračníku farmakoterapie genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051247
- 003
- CZ-PrNML
- 005
- 20140408110904.0
- 007
- ta
- 008
- 140401s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1871520611313050015 $2 doi
- 035 __
- $a (PubMed)22721392
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Stanislav, John
- 245 14
- $a The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells / $c J. Stanislav, J. Mls, M. Červinka, E. Rudolf,
- 520 9_
- $a The roles of autophagic cell death and apoptosis induced by topoisomerase inhibitor irinotecan in colon cancer cells with deleted p53 were investigated during 48 h. We report that irinotecan-dependent cytotoxicity and proapoptotic activity were reduced in the present model while autophagy levels significantly increased. Upon p53 transfection, cell demise rates increased, with cells bearing the features of apoptosis and autophagic cell death. The subsequent studies into mechanisms of cell death process revealed the important role of Bax in mediating mitochondrial and lysosomal leakage which might serve as leading signals for both apoptosis and autophagic cell death. These results suggest that different modes of cell death in p53 null colon cancer cells treated with cytostatics (irinotecan) may be activated simultaneously. Moreover, their interactions possibly occur at several stages and aren't mutually exclusive. This might thus lead to a potential synergism with interesting therapeutic ramifications.
- 650 _2
- $a antitumorózní látky fytogenní $x farmakologie $x terapeutické užití $7 D000972
- 650 _2
- $a apoptóza $x účinky léků $x fyziologie $7 D017209
- 650 _2
- $a autofagie $x účinky léků $x fyziologie $7 D001343
- 650 _2
- $a kamptothecin $x analogy a deriváty $x farmakologie $x terapeutické užití $7 D002166
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a nádory tračníku $x farmakoterapie $x genetika $x metabolismus $7 D003110
- 650 _2
- $a HCT116 buňky $7 D045325
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádorový supresorový protein p53 $x nedostatek $x genetika $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mls, Jan $u -
- 700 1_
- $a Červinka, Miroslav $u -
- 700 1_
- $a Rudolf, Emil $u -
- 773 0_
- $w MED00172590 $t Anti-cancer agents in medicinal chemistry $x 1875-5992 $g Roč. 13, č. 5 (2013), s. 811-20
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22721392 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140408110952 $b ABA008
- 999 __
- $a ok $b bmc $g 1018383 $s 849827
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 13 $c 5 $d 811-20 $i 1875-5992 $m Anti-cancer agents in medicinal chemistry $n Anticancer Agents Med Chem $x MED00172590
- LZP __
- $a Pubmed-20140401